Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorErol, R. Selvinaz
dc.contributor.authorZuhur, Sayid Shafi
dc.contributor.authorÖztürk, F. Yener
dc.contributor.authorŞen, Esra Çil
dc.contributor.authorYıldız, Ayşegül Mavi
dc.contributor.authorCanat, M. Masum
dc.contributor.authorErol, M. Kazım
dc.date.accessioned2023-04-20T08:04:13Z
dc.date.available2023-04-20T08:04:13Z
dc.date.issued2022
dc.identifier.issn0393-6384
dc.identifier.issn2283-9720
dc.identifier.urihttps://doi.org/10.19193/0393-6384_2022_1_60
dc.identifier.urihttps://hdl.handle.net/20.500.11776/11021
dc.description.abstractBackground: To determine the relationship between grade of diabetic retinopathy and serum vitamin D levels in diabetic Methods: The study included a total of 173 diabetic patients consisting of patients without retinopathy ( n=67), patients with non proliferative diabetic retinopathy (NPDRP group n=47), patients with proliferative diabetic retinopathy (PDRP group n=59). Age and sex-matched 55 healthy subjects was taken as a control group. Patients with type 1 DM, those taking vitamin D, multivitamin including vitamin D, drug affecting vitamin D metabolism like rifampin, phenytoin was excluded from the study. Patients with chronic renal failure was also excluded. Dilated fundoscopic examination of all subject was done and serum creatinine, Hb A1c, 25 hydroxyvitamin D (25 (OH) D) level of all subject were measured between may 2012 and September 2012 Results: There were no statistical difference in age, sex, systolic tension, diastolic tension and body mass index between groups. Serum creatinine level was also not statistically different between groups (p = 0.11). Serum fasting glucose and HbA1c level were significantly lower in the control group than diabetic groups (p < 0.001). The mean 25 (OH)D levels of PDRP group, NPDRP group, diabetic patients without retinopathy and control group were 11,9 +/- 6,4 ng/ml, 18,8 +/- 10,2 ng/ml, 16,6 +/- 7,5 ng/ml and 20,1 +/- 9,2 ng/ml respectively. There was statistically significant difference between the PDRP group and other groups in univariate analysis (p < 0.001). When 173 diabetic patients, were compared, with control group, 25 (OH) D levels were significantly lower in diabetic patients than control group regardless of retinopathy status (p = 0.004). Conclusions: Diabetic patients especially, patients with proliferative diabetic retinopathy had lower serum vitamin D levels than healthy subjects. Additionally randomized, controlled, prospective studies are necessary to determine whether vitamin D treatment will stop or slow the progression of diabetic retinopathy in diabetic patients.en_US
dc.language.isoengen_US
dc.publisherCarbone Editoreen_US
dc.identifier.doi10.19193/0393-6384_2022_1_60
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDiabetic Retinopathyen_US
dc.subjectVitamin Den_US
dc.subjectDiabetes Mellitusen_US
dc.subjectProliferative Diabetic Retinopathyen_US
dc.subject1-Alpha,25-Dihydroxyvitamin D-3en_US
dc.subjectRetinopathyen_US
dc.titleTHE EFFECT OF VITAMIN-D ON THE DIABETIC RETHINOPATHYen_US
dc.typearticleen_US
dc.relation.ispartofActa Medica Mediterraneaen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume38en_US
dc.identifier.issue1en_US
dc.identifier.startpage371en_US
dc.identifier.endpage376en_US
dc.institutionauthorZuhur, Sayid Shafi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.wosWOS:000792797700010en_US
dc.identifier.scopus2-s2.0-85124666043en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster